Rutherford has entered into a £55m development framework agreement with Equitix Limited. Under of the terms of the agreement, Rutherford and Equitix will establish up to five new diagnostic facilities in the UK, to provide diagnostic services to the NHS and to private patients. Each centre will provide a variety of diagnostics services including Positron Emission Tomography–Computed Tomography, Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Endoscopy, X-Ray and other relevant diagnostic services...
ACD/Labs, an informatics company that develops and commercializes software in support of R&D,has announced that ACD/ChemSketch Freeware has been downloaded by over two million users worldwide. This free version of ChemSketch, intended for academic and personal use, has been accessible for more than two decades to students, academics, and scientists to communicate research and create teaching materials....
Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, has announced that it has entered into an agreement to acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud. BioBright is a privately-owned scientific lab data automation company based in Boston, MA, dedicated to creating the smart laboratory of the future driven by the move to data-centric research....
Labforward introduces Well Plate Templates and the Tecan Connector App* add-ons for their Labfolder electronic lab notebook software that offers connectivity with Tecan microplate readers. Laboratories increasingly require an easy-to-use solution that integrates lab equipment into the larger workflow, with access to key instrument functionality and electronic data capture...
The University of Glasgow has been awarded £38m to create the Precision Medicine Living Lab – an internationally leading project focused on translating cutting-edge science and innovation into a real world clinical setting. The Living Lab will be situated on University of Glasgow premises adjacent to the Queen Elizabeth University Hospital Campus in Govan. The government funding is provided through UK Research and Innovation’s flagship Strength in Places Fund, and was announced by Alok Sharma....
Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment....
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data. In mid-May Avacta provided Affimer reagents that are specific to the SARS-COV-2 spike protein to Cytiva which has now developed the first lateral flow test strips...
The Royal Society reports that every £1 invested in medical research delivers a return equivalent of around 25 pence every year, forever. Due to the current global situation, many of these vital investments are on hold. However, the sector is adapting to the new landscape. Here, Katie Gray, senior marketing executive at Lab Innovations, explains how UK laboratories are remaining productive during the lockdown...
Since March, Attana has been assisting the team of Prof Ali Salanti at the University of Copenhagen in their development of a COVID-19 vaccine together with the Prevent-nCov consortium. Their vaccine is based on the Capsid Virus-Like Particle (cVLP) technology where coronavirus antigens are attached to the cVLP allowing the body’s immune system to respond to the antigens and produce antibodies....
Researchers in the Department of Pharmacy at the Ludwig Maximilian University of Munich are using chips from Dolomite Microfluidics to reliably and consistently produce monodisperse particles for targeted delivery of small interfering RNA (siRNA) therapeutics. This microfluidic encapsulation technology is ideal for gene silencing applications in cancer immunology and inflammatory diseases, where siRNA can potentially be used to down-regulate genes associated with these pathologies....
The COVID-19 pandemic has placed unprecedented pressure on clinical research and diagnostic laboratories to process more samples, much more quickly. INTEGRA Biosciences offers a range of pipetting systems designed to speed up PCR-based screening workflows, without requiring complex installations or needing lab staff to spend time undertaking specialist training and developing new protocols....
An advanced laboratory dedicated to leading Wales’ national Covid-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies. Creating a national Covid-19 testing lab at the University Hospital of Wales is an important part of the Welsh Government’s Test, Trace, Protect strategy and has been made possible thanks to the support...
Today’s High Tech laboratory environment demands the best results, achieved using the latest safety and production solutions. Combined with the best consumables and equipment HPLC is a powerful tool in analysis, a must for today’s results driven, cost conscious laboratory. Whatever HPLC/UHPLC method is used in the laboratory, choosing the right solvents, safety handling equipment and filtration method is...
A Danish pipetting robot is automating Covid testing processes in hospitals around Europe. The robot, called flowbot ONE, significantly reduces the time it takes for laboratories to produce results for patients to tell them whether they are infected with Covid-19. A unique liquid-handling robot from Denmark is now speeding up the great task of analysing Covid tests....
Four leading participants from the problem-solving exercise will provide facts and data-driven insights on their methodology as well as steps forward to accelerate global recovery from Covid-19 and build the infrastructure to combat future public health crises. This live, virtual event will include an audience Q&A. The six-part series is hosted by the Life Science business of Merck....
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in. Also, the companies will make every effort to support the pharma industry’s priorities for overall medication supply in addition to Covid-19 drugs...
Analytik Jena, a specialist for analytical and bioanalytical laboratory measurement technology is celebrating its 30th anniversary. On this occasion, Analytik Jena would like to focus this year on those who have accompanied and shaped the company over the years: customers, partners and employees. With the motto "30 Years. 30 Stories."...
Thermo Fisher Scientific, the world leader in serving science, and MSAID GmbH, a software company transforming proteomics with deep learning, announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID's Prosit-derived framework widely accessible to proteomics laboratories. The availability of deep learning tools will enable improved confidence in proteomics research results, primarily in the areas of protein profiling using label-free or tandem mass tag (TMT)-based quantification, and a variety of new applications....
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is supporting Professor Sachin Gupte, a pharmacologist at the New York Medical College (Valhalla, NY, USA), in his endeavours to find a drug treatment for the lung damage that can result from Covid-19 infection. Sygnature has synthesised two important compounds, which Prof Gupte will test in a model of coronavirus-induced lung injury. Sygnature’s work has been undertaken on a pro bono basis.
Thermo Fisher Scientific, the world leader in serving science, recognizes the winners of the 2020 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its sixth year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using TMT. The proprietary TMT and TMTpro reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC....
First solution for simultaneous gene perturbation measurement and unbiased single-cell gene expression. Merck, a leading science and technology company, and 10x Genomics, Inc., a single cell and spatial genomics technologies company, have announced that they have developed a powerful new option for biological experiments. “Researchers today require more detailed information to better understand the relationship between specific genes and disease...
Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs) while lowering costs, announces the launch of its new cell-based vaccine platform targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, as well as other viral diseases such as Zika, West Nile Virus, Yellow Fever, Dengue Fever, MERS, HCV and Cytomegalovirus infection (CMV)....
Rutherford has entered into a £55m development framework agreement with Equitix Limited. Under of the terms of the agreement, Rutherford and Equitix will establish up to five new diagnostic facilities in the UK, to provide diagnostic services to the NHS and to private patients. Each centre will provide a variety of diagnostics services including Positron Emission Tomography–Computed Tomography, Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Endoscopy, X-Ray and other relevant diagnostic services...
ACD/Labs, an informatics company that develops and commercializes software in support of R&D,has announced that ACD/ChemSketch Freeware has been downloaded by over two million users worldwide. This free version of ChemSketch, intended for academic and personal use, has been accessible for more than two decades to students, academics, and scientists to communicate research and create teaching materials....
Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, has announced that it has entered into an agreement to acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud. BioBright is a privately-owned scientific lab data automation company based in Boston, MA, dedicated to creating the smart laboratory of the future driven by the move to data-centric research....
Labforward introduces Well Plate Templates and the Tecan Connector App* add-ons for their Labfolder electronic lab notebook software that offers connectivity with Tecan microplate readers. Laboratories increasingly require an easy-to-use solution that integrates lab equipment into the larger workflow, with access to key instrument functionality and electronic data capture...
The University of Glasgow has been awarded £38m to create the Precision Medicine Living Lab – an internationally leading project focused on translating cutting-edge science and innovation into a real world clinical setting. The Living Lab will be situated on University of Glasgow premises adjacent to the Queen Elizabeth University Hospital Campus in Govan. The government funding is provided through UK Research and Innovation’s flagship Strength in Places Fund, and was announced by Alok Sharma....
Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment....
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data. In mid-May Avacta provided Affimer reagents that are specific to the SARS-COV-2 spike protein to Cytiva which has now developed the first lateral flow test strips...
The Royal Society reports that every £1 invested in medical research delivers a return equivalent of around 25 pence every year, forever. Due to the current global situation, many of these vital investments are on hold. However, the sector is adapting to the new landscape. Here, Katie Gray, senior marketing executive at Lab Innovations, explains how UK laboratories are remaining productive during the lockdown...
Since March, Attana has been assisting the team of Prof Ali Salanti at the University of Copenhagen in their development of a COVID-19 vaccine together with the Prevent-nCov consortium. Their vaccine is based on the Capsid Virus-Like Particle (cVLP) technology where coronavirus antigens are attached to the cVLP allowing the body’s immune system to respond to the antigens and produce antibodies....
Researchers in the Department of Pharmacy at the Ludwig Maximilian University of Munich are using chips from Dolomite Microfluidics to reliably and consistently produce monodisperse particles for targeted delivery of small interfering RNA (siRNA) therapeutics. This microfluidic encapsulation technology is ideal for gene silencing applications in cancer immunology and inflammatory diseases, where siRNA can potentially be used to down-regulate genes associated with these pathologies....
The COVID-19 pandemic has placed unprecedented pressure on clinical research and diagnostic laboratories to process more samples, much more quickly. INTEGRA Biosciences offers a range of pipetting systems designed to speed up PCR-based screening workflows, without requiring complex installations or needing lab staff to spend time undertaking specialist training and developing new protocols....
An advanced laboratory dedicated to leading Wales’ national Covid-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies. Creating a national Covid-19 testing lab at the University Hospital of Wales is an important part of the Welsh Government’s Test, Trace, Protect strategy and has been made possible thanks to the support...
Today’s High Tech laboratory environment demands the best results, achieved using the latest safety and production solutions. Combined with the best consumables and equipment HPLC is a powerful tool in analysis, a must for today’s results driven, cost conscious laboratory. Whatever HPLC/UHPLC method is used in the laboratory, choosing the right solvents, safety handling equipment and filtration method is...
A Danish pipetting robot is automating Covid testing processes in hospitals around Europe. The robot, called flowbot ONE, significantly reduces the time it takes for laboratories to produce results for patients to tell them whether they are infected with Covid-19. A unique liquid-handling robot from Denmark is now speeding up the great task of analysing Covid tests....
Four leading participants from the problem-solving exercise will provide facts and data-driven insights on their methodology as well as steps forward to accelerate global recovery from Covid-19 and build the infrastructure to combat future public health crises. This live, virtual event will include an audience Q&A. The six-part series is hosted by the Life Science business of Merck....
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in. Also, the companies will make every effort to support the pharma industry’s priorities for overall medication supply in addition to Covid-19 drugs...
Analytik Jena, a specialist for analytical and bioanalytical laboratory measurement technology is celebrating its 30th anniversary. On this occasion, Analytik Jena would like to focus this year on those who have accompanied and shaped the company over the years: customers, partners and employees. With the motto "30 Years. 30 Stories."...
Thermo Fisher Scientific, the world leader in serving science, and MSAID GmbH, a software company transforming proteomics with deep learning, announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID's Prosit-derived framework widely accessible to proteomics laboratories. The availability of deep learning tools will enable improved confidence in proteomics research results, primarily in the areas of protein profiling using label-free or tandem mass tag (TMT)-based quantification, and a variety of new applications....
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is supporting Professor Sachin Gupte, a pharmacologist at the New York Medical College (Valhalla, NY, USA), in his endeavours to find a drug treatment for the lung damage that can result from Covid-19 infection. Sygnature has synthesised two important compounds, which Prof Gupte will test in a model of coronavirus-induced lung injury. Sygnature’s work has been undertaken on a pro bono basis.
Thermo Fisher Scientific, the world leader in serving science, recognizes the winners of the 2020 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its sixth year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using TMT. The proprietary TMT and TMTpro reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC....
First solution for simultaneous gene perturbation measurement and unbiased single-cell gene expression. Merck, a leading science and technology company, and 10x Genomics, Inc., a single cell and spatial genomics technologies company, have announced that they have developed a powerful new option for biological experiments. “Researchers today require more detailed information to better understand the relationship between specific genes and disease...
Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs) while lowering costs, announces the launch of its new cell-based vaccine platform targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, as well as other viral diseases such as Zika, West Nile Virus, Yellow Fever, Dengue Fever, MERS, HCV and Cytomegalovirus infection (CMV)....